Mutaib Mosaued Mashraqi

20PUBLICATIONS
52CO-AUTHORS
Molecular targetsSolid tumoursMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|May 09, 2025
Evaluating the polypharmacological potency of indenopyrazole against lung cancer oxidoreductase, chaperone, transferase, and hydrolase proteins.

Youssef Saeed Alghamdi, Mutaib M Mashraqi, Ohud Alsalmi

|Nov 06, 2024
Potential Target Metabolites From Gut Microbiota Against Hepatocellular Carcinoma: A Network Pharmacology and Molecular Docking Study.

Sehar Aslam, Muhammad Qasim, Fatima Noor

|Feb 24, 2024
Structure-Based In Silico Approaches Reveal IRESSA as a Multitargeted Breast Cancer Regulatory, Signalling, and Receptor Protein Inhibitor.

Hassan Hussain Almasoudi, Mutaib M Mashraqi, Saleh A Alshamrani

|Oct 19, 2023
Variolin B from sea sponge against lung cancer: a multitargeted molecular docking with fingerprinting and molecular dynamics simulation study.

Ohud Alsalmi, Mutaib M Mashraqi, Saleh Alshamrani

|Sep 29, 2023
Molecular screening reveals Variolin B as a multitargeted inhibitor of lung cancer: a molecular docking-based fingerprinting and molecular dynamics simulation study.

Hassan H Almasoudi, Mutaib M Mashraqi, Saleh Alshamrani

Pageof 4